Greater clinical benefit for patients with brain disorders and gains in cost-effectiveness for society – both can be achieved by earlier intervention, closer co-ordination of multidisciplinary care, and disseminating best practices in treatment. Parkinson’s Disease, Alzheimer’s Disease and schizophrenia are among the areas considered in detail by the European Brain Council’s Value of Treatment initiative.

Related content

description Article
Global perspectives on Alzheimer’s disease diagnosis and treatment: challenges and considerations in resource-limited settings

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease and the leading cause of dementia worldwide, regardless of socioeconomic status.

09.07.2024 Alzheimer’s Disease
grid_view Slide Deck
Alzheimer’s disease – History, definitions and diagnosis

Dementia is an umbrella term used to describe a state where an individual has lost the ability to carry out daily life activities independently because of cognitive impairment that is not due to an underlying psychiatric condition. Alzheimer’s disease (AD) refers to the abnormal presence of Aβ and tau proteins, which define AD among many other neurodegenerative diseases. Dementia -including dementia due to AD- is likely to be underestimated because of underdiagnosis and misdiagnosis.

15.12.2023 Alzheimer’s Disease
image Image 10 warning signs of dementia
10 warning signs of dementia

Usually, the first step for individuals with cognitive complaints in most countries is to visit their primary care physicians

15.12.2023 Alzheimer’s Disease